If you’re a patent practitioner who works with innovation related to artificial intelligence, you’ll want to consider the Federal Circuit’s recent decision in Recentive Analytics, Inc. v. Fox. Corp. This decision is the first to explicitly consider patent eligibility in the context of the use of artificial intelligence. The Federal Circuit affirmed the district court’s … Continue Reading
On February 19, 2014, Squire Sanders associate Django H. Andrews lead a BayBio Lunch & Learn session regarding the patent eligibility of Biomarker innovation in the US and abroad. The session focused on patent eligibility of Biomarkers in the US after the Prometheus and Myriad Supreme Court decisions, as well as patent eligibility in Europe … Continue Reading
